Capital World Investors
HALO icon

Capital World Investors’s Halozyme HALO Stock Holding History

Capital World Investors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-871,902
Closed -$56.4M – 661
2026
Q1 		$56.4M Sell
871,902
-7,972
-0.9% -$562K 0.01% 444
2025
Q4 		$59.2M Buy
879,874
+48,218
+6% +$3.24M 0.01% 398
2025
Q3 		$61M Buy
831,656
+49,652
+6% +$3.3M 0.01% 390
2025
Q2 		$40.7M Buy
782,004
+33,774
+5% +$1.92M 0.01% 430
2025
Q1 		$47.7M Hold
748,230
– – 0.01% 397
2024
Q4 		$35.8M Buy
+748,230
New +$38.4M 0.01% 432

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital World Investors's HALO Position: Q2 2026 in Review

Capital World Investors sold out of Halozyme (HALO) in Q2 2026, closing a stake of 871,902 shares — an estimated $56.4M sold.

Capital World Investors first reported a position in HALO in Q4 2024 and held it in 6 quarters. The position peaked at $61M in Q3 2025. 528 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Capital World Investors reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Capital World Investors sold 871,902 Halozyme shares in Q2 2026, an estimated $56.4M.
  • Capital World Investors first reported a position in Halozyme in Q4 2024 and held it in 6 quarters.
  • Capital World Investors's Halozyme position peaked at $61M in Q3 2025.
  • 528 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.